University of Wisconsin, Madison
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Wisconsin, Madison sits in the top decile of US sponsors by registered trial count (#31 of 15,742 sponsors by registered trial count).
University of Wisconsin, Madison: 1,039 sponsored US clinical trials, 151 recruiting.
University of Wisconsin, Madison sponsors 1,039 registered US clinical trials on ClinicalTrials.gov, 151 of them currently recruiting, and 712 completed. 98 of these trials are in Phase 3-4 (later-stage) and 251 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Healthy, with 10 trials.
Top-decile sponsor footprint
University of Wisconsin, Madison ranks in the top decile of sponsors by registered trial count (#31 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
712 of 824 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (86.4%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,039 total, page 9 of 21
Fit Families Program: Fundamental Motor Skill Intervention in Children With Autism Spectrum Disorders and Their Parents
NCT04612647
Research Engagement With People With Intellectual and Developmental Disabilities
NCT04182347
CLR 131 Combined With Radiation for Head and Neck Cancer
NCT04105543
Alterations in the Vaginal Microenvironment Using a Non-pharmacological Intervention
NCT03739983
Oral Fecal Microbiota Transplant Feasibility Study in Alzheimer's Disease
NCT03998423
Cardiac Metabolic Remodeling After Pulmonary Vasodilator Therapy in Pulmonary Arterial Hypertension: A Pilot Study
NCT04090866
Mixed Methods Investigation of Chronic Facial Paralysis in Individuals With Synkinesis
NCT04148872
Examining the Efficacy of Acceptance and Commitment Therapy (ACT) Microinterventions for Distressed First-Generation College Students
NCT04081662
Salivary Gland Autotransplantation for Treatment of XRT Induced Xerostomia
NCT04007081
Well-being and the HM App Pilot (WHAP) Study
NCT04139005
Botox for the Treatment of Chronic Exertional Compartment Syndrome
NCT03922139
AlloSure for the Monitoring of Antibody Mediated Processes After Kidney Transplantation
NCT04057742
Insulin Resistance in Adolescents
NCT04089332
Today Not Tomorrow Pregnancy and Infant Support Program (TNT- PISP)
NCT04100577
A Dose-Escalation Study Evaluating Safety and Tolerability of Viral-Specific T Cells Against CMV in Adult Solid Organ Transplant Recipients
NCT03950414
Novel Application of Indocyanine Green as a Biomarker to Identify Tissue Necrosis in Mastectomy Patients
NCT04145323
Slow-wave Enhancement in Adults Aged 30-49
NCT04611828
Modeling Mood Course to Detect Markers for Effective Adaptive Interventions- Aim 3
NCT04098497
Down Syndrome Speech Intelligibility Diagnostic Treatment Study
NCT04059354
E-health Implementation (Iowa)
NCT03954184
Effectiveness of Urinary Alkalinizing Agents on Kidney Stone Risk
NCT04095975
Pain, Psychological, and Endocannabinoid Responses to Yoga in Breast Cancer Survivors With Chemotherapy-induced Neuropathic Pain
NCT04075097
Clinical Trial Evaluating the Efficiency of Holmium Laser Settings on Urinary Stones
NCT03526458
Evaluation and Treatment of Iron Deficiency in Ovarian Cancer Patients
NCT03933813
Acetazolamide Challenge With Perfusion in the Prediction of Cerebral Vasospasm
NCT03377049
Analysis of Electrocorticographic Signals
NCT03785028
Improving Diabetes Medication Adherence for African Americans in Madison and Milwaukee Through Peer Support
NCT04028076
Faith and Community in Action: Increasing Awareness and Management of Depression in African American Communities
NCT03940157
Control of Pain in Intravitreal Injections Using Topical NSAIDs
NCT04343222
A Pilot Study of the Learn, Connect, and Quit Mobile Application
NCT03978455
Epigenetic Impact of a Psychotherapeutic Program in Adolescents With Severe Adverse Experiences
NCT04103541
Mind Over Matter: Electronic Bladder and Bowel Continence Self-management Program
NCT03976414
Robotic Pedaling Therapy for Targeted Neural Plasticity
NCT03300258
Yoga for Seniors
NCT04889131
Immunogenicity of Herpes Zoster Subunit Vaccine in Inflammatory Bowel Disease Patients Treated With Vedolizumab
NCT03798691
CAMPath and BELimumab for Transplant Tolerance in Sensitized Kidney Transplant Recipients
NCT03591380
Impact of Quadratus Lumborum Block on Recovery Profile After Ventral Hernia Repair
NCT03794882
FQ Restriction for the Prevention of CDI
NCT03848689
Cetuximab in Head and Neck Cancer Patients
NCT03769311
Surgical Treatment for Great Toe Arthritis
NCT03935880
Glycomacropeptide and Women's Health
NCT05551091
Exercise and Therapeutic Learning Among Women With PTSD
NCT04113798
Implementation of a Web-based Decision Aid for Breast Cancer Surgery
NCT03304002
Youth Health and Social Media
NCT03881397
A Longitudinal Evaluation of a Radiotracer for Use in Tau Tracking
NCT03919669
The GRAFT Study: Gut RecolonizAtion by Fecal Transplantation
NCT03621657
Envarsus in Delayed Graft Function (E-DGF)
NCT03864926
ART-CHESS: A Mobile Health Application to Support People Living With HIV and Addiction
NCT03873129
E-Cigarette Effects on Markers of Cardiovascular and Pulmonary Disease
NCT03863509
PTSD Treatment for Incarcerated Men and Women
NCT03891797
What is open in the University of Wisconsin, Madison pipeline
151 recruiting of 1,039 indexed (15% open); 712 completed (69%).
Phase mix: 98 late (III/IV) vs 251 early (I/II) (early-phase heavy).
Top condition: Healthy (10 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Wisconsin, Madison: open-pipeline peers nationwide
Peers matched on 1,039 registered trials and 15% open enrollment, not the therapeutic-area sidebar.
University of Wisconsin, Madison sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,039 trials (± recruiting share)
- University of Washington · 1,048 trials · 15% recruiting
- Bristol-Myers Squibb · 1,025 trials · 7% recruiting
- University of Florida · 1,106 trials · 15% recruiting
- University of North Carolina, Chapel Hill · 1,109 trials · 10% recruiting
Sponsors near 15% open enrollment (± trial volume)
- Masonic Cancer Center, University of Minnesota · 14% recruiting · 249 trials
- ModernaTX · 14% recruiting · 90 trials
- United States Naval Medical Center, San Diego · 15% recruiting · 41 trials
- The Cleveland Clinic · 14% recruiting · 688 trials
Related
What to do with this University of Wisconsin, Madison page
1,039 registered trials is a research-attention snapshot, not an endorsement of University of Wisconsin, Madison or any single study.
- 151 of University of Wisconsin, Madison's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Healthy is the condition University of Wisconsin, Madison studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Healthy trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Wisconsin, Madison pipeline card: 1,039 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.